NCT05119907 2025-11-17
Study of Sacituzumab Govitecan in Patients With Solid Tumor
Gilead Sciences
Phase 2 Active not recruiting
Clinical Trials
4 trialsNCT05642780 2025-10-14
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
Klus Pharma Inc.
Phase 2 Active not recruiting
NCT04185831 2024-08-22
MEGALiT
Uppsala University Hospital
Phase 2 Active not recruiting
NCT03865082 2022-02-17
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
Idera Pharmaceuticals, Inc.
Phase 2 Active not recruiting